MedPath

河北一品制药股份有限公司

Ownership
-
Established
2013-05-29
Employees
-
Market Cap
-
Website
www.hbypzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

NMPA:33

Drug Approvals

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20254188
Approval Date
May 13, 2025
NMPA

Iron Proteinsuccinylate Oral Solution

Product Name
蛋白琥珀酸铁口服溶液
Approval Number
国药准字H20253461
Approval Date
Feb 25, 2025
NMPA

Pentoxifylline Injection

Product Name
己酮可可碱注射液
Approval Number
国药准字H20249322
Approval Date
Nov 15, 2024
NMPA

Granisetron Hydrochloride Injection

Product Name
盐酸格拉司琼注射液
Approval Number
国药准字H20093416
Approval Date
Aug 18, 2023
NMPA

Clindamycin Phosphate for Injection

Product Name
注射用克林霉素磷酸酯
Approval Number
国药准字H20093506
Approval Date
Aug 18, 2023
NMPA

D,L-α-Hydroxymethionine Calcium

Product Name
消旋羟蛋氨酸钙
Approval Number
国药准字H20084633
Approval Date
Jun 8, 2023
NMPA

Ketovaline Calcium

Product Name
酮缬氨酸钙
Approval Number
国药准字H20084600
Approval Date
Jun 8, 2023
NMPA

α-Ketoleucine Calcium

Product Name
酮亮氨酸钙
Approval Number
国药准字H20084611
Approval Date
Jun 8, 2023
NMPA

D,L-α-Ketoisoleucine Calcium

Product Name
消旋酮异亮氨酸钙
Approval Number
国药准字H20084602
Approval Date
Jun 8, 2023
NMPA

α-Ketophenylalanine Calcium

Product Name
酮苯丙氨酸钙
Approval Number
国药准字H20093057
Approval Date
Jun 8, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.